Pentraxin-3 as a Marker of both the Presence and the Severity of Metabolic Syndrome

Publisher： Karger

E-ISSN： 1423-0151|23|4|390-390

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.23, Iss.4, 2014-01, pp. : 390-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serum Pentraxin-3 Levels Are Associated with the Severity of Metabolic Syndrome

By  

Medical Principles and Practice, Vol. 22, Iss. 3, 2012-11 ,pp. : 274-279

Karger

Access to resources Recommend Favorite

Higher Pentraxin-3 Level in Patients with Metabolic Syndrome

By  

Medical Principles and Practice, Vol. 22, Iss. 5, 2013-07 ,pp. : 513-514

Karger

Access to resources Recommend Favorite

Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 4, 2005-10 ,pp. : 377-381

Bentham Science Publishers

Access to resources Recommend Favorite

Progression of Metabolic Syndrome Severity During the Menopausal Transition

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 8, 2016-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

By Aydogdu Aydogan   Tasci Ilker   Tapan Serkan   Basaran Yalcin   Aydogan Umit   Meric Coskun   Sonmez Alper   Aydogdu Sebnem   Akbulut Halil   Taslipinar Abdullah   Uckaya Gokhan   Azal Omer  

Gynecological Endocrinology, Vol. 28, Iss. 9, 2012-09 ,pp. : 722-725

Informa Healthcare

Access to resources Recommend Favorite